Skip to content
MedsAcross

Manufacturer

Indoco Remedies

Pharmaceutical manufacturer based in India
Indian manufacturerIndia
Products listed
32
Molecules
13
Therapy areas
4

Indoco Remedies is a pharmaceutical manufacturer based in India. MedsAcross lists 32 of its products across 13 molecules, each with registers, packs and availability for export supply to licensed buyers.

Country
India
Indian manufacturer
Yes
Also listed as
Indoco Remedies Limited
US FDA labeler
YesSource: openFDA NDC directory

Source from this manufacturer

We supply Indoco Remedies products through licensed channels, with the documents your regulator needs.

Neurology

16 presentations

Neurology overview
MedicineActive ingredientRegisterAvailability
Lacosamide 100 mg tabletOralGeneric nameLacosamideUS FDAAvailable on request
Lacosamide 150 mg tabletOralGeneric nameLacosamideUS FDAAvailable on request
Lacosamide 200 mg tabletOralGeneric nameLacosamideUS FDAAvailable on request
Lacosamide 200 mg/20 mL injectionIntravenousGeneric nameLacosamideUS FDAAvailable on request
Lacosamide 50 mg tabletOralGeneric nameLacosamideUS FDAAvailable on request
Lofexidine 0.18 mg tabletOralGeneric nameLofexidineUS FDAAvailable on request
Pregabalin 100 mg capsuleOralGeneric namePregabalinUS FDAAvailable on request
Pregabalin 150 mg capsuleOralGeneric namePregabalinUS FDAAvailable on request
Pregabalin 200 mg capsuleOralGeneric namePregabalinUS FDAAvailable on request
Pregabalin 225 mg capsuleOralGeneric namePregabalinUS FDAAvailable on request
Pregabalin 25 mg capsuleOralGeneric namePregabalinUS FDAAvailable on request
Pregabalin 300 mg capsuleOralGeneric namePregabalinUS FDAAvailable on request
Pregabalin 50 mg capsuleOralGeneric namePregabalinUS FDAAvailable on request
Pregabalin 75 mg capsuleOralGeneric namePregabalinUS FDAAvailable on request
Varenicline 0.5 mg tabletOralGeneric nameVareniclineUS FDAAvailable on request
Varenicline 1 mg tabletOralGeneric nameVareniclineUS FDAAvailable on request

Haematology

6 presentations

Haematology overview
MedicineActive ingredientRegisterAvailability
Apixaban 2.5 mg tabletOralGeneric nameApixabanUS FDAAvailable on request
Apixaban 5 mg tabletOralGeneric nameApixabanUS FDAAvailable on request
Rivaroxaban 10 mg tabletOralGeneric nameRivaroxabanUS FDAAvailable on request
Rivaroxaban 15 mg tabletOralGeneric nameRivaroxabanUS FDAAvailable on request
Rivaroxaban 2.5 mg tabletOralGeneric nameRivaroxabanUS FDAAvailable on request
Rivaroxaban 20 mg tabletOralGeneric nameRivaroxabanUS FDAAvailable on request

Ophthalmology

3 presentations

Ophthalmology overview
MedicineActive ingredientRegisterAvailability
Acetylcysteine 6000 mg/30 mL injectionIntravenousGeneric nameAcetylcysteineUS FDAAvailable on request
Brimonidine 2 mg/mg eye dropsOphthalmicGeneric nameBrimonidineUS FDAAvailable on request
Dorzolamide 20 mg/mL eye dropsOphthalmicGeneric nameDorzolamideUS FDAAvailable on request

Rheumatology

3 presentations

Rheumatology overview
MedicineActive ingredientRegisterAvailability
Allopurinol 100 mg tabletOralGeneric nameAllopurinolUS FDAAvailable on request
Allopurinol 200 mg tabletOralGeneric nameAllopurinolUS FDAAvailable on request
Allopurinol 300 mg tabletOralGeneric nameAllopurinolUS FDAAvailable on request

Other products

4 presentations

MedicineActive ingredientRegisterAvailability
Dorzolamide Hydrochloride Timolol Maletae 20 mg/5 mg per mL eye dropsOphthalmicDorzolamide and TimololUS FDAAvailable on request
Neostigmine methylsulfate 10 mg/10 mL injectionIntravenousGeneric nameNeostigmine methylsulfateUS FDAAvailable on request
Neostigmine methylsulfate 5 mg/10 mL injectionIntravenousGeneric nameNeostigmine methylsulfateUS FDAAvailable on request
Succinylcholine 200 mg/10 mL injectionIntramuscular, intravenous Cold chainGeneric nameSuccinylcholineUS FDAAvailable on request

Molecules made

Manufacturer facts come from public registers and are shown with their source. Listing does not mean the manufacturer endorses MedsAcross.

Source from Indoco Remedies

Send a request for any of these products. We confirm the licensed source, documents and lead time.